The global endovascular treatment devices market was valued at US$ 3.7 Bn in 2025 and is projected to reach US$ 9.7 Bn by 2036, expanding at a CAGR of 9.2% from 2026 to 2036. Market growth is primarily driven by the rising prevalence of cardiovascular and peripheral vascular diseases, coupled with increasing demand for minimally invasive treatment procedures such as angioplasty, stenting, and thrombectomy.

Access key findings and insights from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=56028 

Market Overview

Endovascular treatment devices are specialized medical instruments designed to treat vascular diseases using minimally invasive techniques. These devices are inserted into blood vessels through catheter-based approaches, enabling physicians to diagnose and repair vascular abnormalities without the need for open surgery.

The growing preference for minimally invasive procedures is significantly influencing market expansion, as these treatments offer reduced complications, shorter hospital stays, and faster recovery times compared to traditional surgical methods. The increasing burden of lifestyle-related diseases such as diabetes, hypertension, and obesity is further contributing to the demand for advanced vascular interventions.

Technological advancements in device design, including drug-eluting stents, improved catheters, and imaging-guided navigation systems, are enhancing procedural precision and patient outcomes. As healthcare systems worldwide continue to shift toward value-based care, endovascular therapies are gaining widespread acceptance among both healthcare providers and patients.

Key Market Growth Drivers

Rising Prevalence of Cardiovascular & Vascular Diseases

The increasing incidence of cardiovascular diseases, including peripheral artery disease (PAD), aneurysms, and thrombosis, is a major factor driving the growth of the endovascular treatment devices market. Aging populations, sedentary lifestyles, and poor dietary habits are contributing to the rising number of patients requiring vascular interventions.

Endovascular therapies offer a safer and less invasive alternative to open surgeries, making them highly preferred among patients and clinicians. These procedures reduce trauma, lower complication rates, and enable quicker recovery, thereby driving their adoption globally.

Technological Advancements in Devices

Continuous innovation in endovascular technologies is significantly boosting market growth. Advancements in stents, balloon catheters, stent-grafts, embolic protection systems, and thrombectomy devices are improving the accuracy and effectiveness of vascular procedures.

Emerging technologies such as bioresorbable materials, robotics-assisted interventions, drug-eluting stents, and AI-based imaging guidance are further transforming the landscape of vascular care. These innovations not only enhance patient safety and clinical outcomes but also expand the range of treatable vascular conditions.

Analysis of Key Players

The global endovascular treatment devices market is highly competitive, with key players including Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Cardinal Health, Endospan Ltd., Lombard Medical, Abbott Laboratories, Cook, W. L. Gore & Associates, Inc., Penumbra, Inc., Cordis Corporation, and Endologix LLC.

These companies are focusing on product innovation, strategic partnerships, and geographic expansion to strengthen their market positions. Their strategies include developing advanced device technologies, improving clinical outcomes, and expanding access to minimally invasive treatments in emerging markets.

Market Challenges & Opportunities

Despite strong growth prospects, the market faces several challenges, including the high cost of endovascular procedures and devices, limited reimbursement policies in certain regions, and stringent regulatory requirements. Additionally, a shortage of skilled interventional specialists capable of performing complex procedures may hinder market expansion.

However, these challenges present opportunities for innovation and growth. Increasing healthcare investments in emerging economies, improving healthcare infrastructure, and rising awareness of minimally invasive treatments are expected to create significant opportunities for market players. The development of cost-effective and technologically advanced devices will further support market penetration.

Recent Developments

• In September 2025, Jupiter Endovascular announced that its Vertex catheter received FDA 510(k) clearance for the insertion of endovascular devices. Jupiter’s Vertex catheter comprises part of the vertex system designed to treat acute pulmonary embolism (PE). The innovative endovascular procedure offers high levels of control and precision.
• In November 2025, Terumo Aortic announced enrolment of the first patient in the Fenestrated TREO pivotal Investigational Device Exemption (IDE) study in the US.
• In October 2025, Medtronic plc announced that it had received U.S. Food and Drug Administration (FDA) labeling approval for the Medtronic Endurant stent graft system, by adding ruptured abdominal aortic aneurysm (rAAA) clinical evidence and removing the rAAA treatment warning.

Explore our report to uncover in-depth insights – https://www.transparencymarketresearch.com/endovascular-treatment-devices-market.html

Market Segmentation

By Device Type

• Percutaneous Endovascular Aneurysm Repair (EVAR) Devices (Largest segment – 28.7% share in 2025)
• Stents
• Balloon Catheters
• Thrombectomy Devices
• Guidewires and Others

The EVAR devices segment dominates the market due to its effectiveness in treating aortic aneurysms through minimally invasive approaches. These devices reduce complications, improve survival rates, and enable faster recovery, making them a preferred choice among clinicians.

By Application

• Cardiovascular Diseases
• Peripheral Vascular Diseases
• Aneurysms
• Others

Regional Outlook

North America (Leading Region – 38.7% Share)

North America holds the largest share in the endovascular treatment devices market, driven by a high prevalence of vascular diseases, advanced healthcare infrastructure, and strong adoption of innovative medical technologies.

The presence of leading medical device manufacturers and well-established reimbursement frameworks supports the rapid adoption of endovascular treatments. Additionally, increasing patient awareness regarding minimally invasive procedures and favorable clinical outcomes further contribute to regional dominance.

Other Regions

• Europe: Strong regulatory environment and growing adoption of advanced vascular technologies
• Asia Pacific: Rapid growth due to expanding healthcare infrastructure and rising disease burden
• Latin America & Middle East & Africa: Increasing investments in healthcare and improving access to advanced treatments

Why Buy This Report?

• Comprehensive analysis of market trends, size, and growth forecasts through 2036
• Detailed insights into key drivers, challenges, and opportunities
• In-depth competitive landscape and company profiling
• Region-wise and segment-wise market analysis
• Strategic insights for investors, manufacturers, and stakeholders

Buy this Premium Research Report for exclusive, in-depth insights – https://www.transparencymarketresearch.com/checkout.php?rep_id=56028&ltype=S

FAQs

1. What is the current size of the endovascular treatment devices market?
   The market was valued at US$ 3.7 Bn in 2025.
2. What is the expected growth rate of the market?
   The market is projected to grow at a CAGR of 9.2% from 2026 to 2036.
3. Which region dominates the market?
   North America leads the market with a 38.7% share.
4. Which segment holds the largest market share?
   EVAR devices dominate with a 28.7% share in 2025.
5. What are the key growth drivers?
   Key drivers include rising cardiovascular diseases and technological advancements in minimally invasive devices.

More Trending Reports by Transparency Market Research –

Companion Diagnostics Market: https://www.transparencymarketresearch.com/companion-diagnostics-market.html

Healthcare Contract Research Outsourcing Market: https://www.transparencymarketresearch.com/hcro-market.html

Cervical Cancer Diagnostic Tests Market: https://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html

Sleep Apnea Devices Market: https://www.transparencymarketresearch.com/sleep-apnea-devices-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com